98 related articles for article (PubMed ID: 11270681)
21. Effect of aminoguanidine treatment on diabetes-induced changes in the myenteric plexus of rat ileum.
Shotton HR; Adams A; Lincoln J
Auton Neurosci; 2007 Mar; 132(1-2):16-26. PubMed ID: 16987713
[TBL] [Abstract][Full Text] [Related]
22. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
Casey RG; Joyce M; Roche-Nagle G; Chen G; Bouchier-Hayes D
J Surg Res; 2005 Feb; 123(2):176-81. PubMed ID: 15680375
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of the angiotensin-converting enzyme inhibitor perindopril on diabetic glomerulopathy in streptozotocin-induced diabetic rats.
Yan L; Yang R; Cheng H; Fu Z; Zhong G; Yan T
Chin Med J (Engl); 1998 Apr; 111(4):306-8. PubMed ID: 10374392
[TBL] [Abstract][Full Text] [Related]
24. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
25. Effects of aminoguanidine and tolrestat on the development of ocular and renal structural changes in experimental diabetic rats.
Azal O; Yönem A; Güler S; Cakir B; Baydar A; Corakçi A; Kutlu M
Diabetes Obes Metab; 2002 Jan; 4(1):75-9. PubMed ID: 11874446
[TBL] [Abstract][Full Text] [Related]
26. Salt blocks the renal benefits of ramipril in diabetic hypertensive rats.
Fabris B; Jackson B; Johnston CI
Hypertension; 1991 Apr; 17(4):497-503. PubMed ID: 1826492
[TBL] [Abstract][Full Text] [Related]
27. Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats.
Chougala MB; Bhaskar JJ; Rajan MG; Salimath PV
Clin Nutr; 2012 Oct; 31(5):749-55. PubMed ID: 22445558
[TBL] [Abstract][Full Text] [Related]
28. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
Wilkinson-Berka JL; Kelly DJ; Koerner SM; Jaworski K; Davis B; Thallas V; Cooper ME
Diabetes; 2002 Nov; 51(11):3283-9. PubMed ID: 12401720
[TBL] [Abstract][Full Text] [Related]
29. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.
Forbes JM; Cooper ME; Thallas V; Burns WC; Thomas MC; Brammar GC; Lee F; Grant SL; Burrell LM; Jerums G; Osicka TM
Diabetes; 2002 Nov; 51(11):3274-82. PubMed ID: 12401719
[TBL] [Abstract][Full Text] [Related]
30. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition.
Cameron NE; Cotter MA
Metabolism; 1996 Sep; 45(9):1147-52. PubMed ID: 8781303
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia in the diabetic kidney is independent of advanced glycation end-products.
Nordquist L; Liss P; Fasching A; Hansell P; Palm F
Adv Exp Med Biol; 2013; 765():185-193. PubMed ID: 22879032
[TBL] [Abstract][Full Text] [Related]
32. Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
Castoldi G; di Gioia CR; Bombardi C; Preziuso C; Leopizzi M; Maestroni S; Corradi B; Zerbini G; Stella A
Am J Nephrol; 2013; 37(1):65-73. PubMed ID: 23327833
[TBL] [Abstract][Full Text] [Related]
33. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.
Sugimoto H; Shikata K; Wada J; Horiuchi S; Makino H
Diabetologia; 1999 Jul; 42(7):878-86. PubMed ID: 10440132
[TBL] [Abstract][Full Text] [Related]
34. Hepatic nitrosative stress in experimental diabetes.
Di Naso FC; Rodrigues G; Simões Dias A; Porawski M; Fillmann H; Marroni NP
J Diabetes Complications; 2012; 26(5):378-81. PubMed ID: 22699114
[TBL] [Abstract][Full Text] [Related]
35. Desulphation of dextran sulphate during kidney ultrafiltration.
Comper WD; Tay M; Wells X; Dawes J
Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):31-4. PubMed ID: 8280107
[TBL] [Abstract][Full Text] [Related]
36. Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.
Chang KC; Hsu KL; Tseng CD; Lin YD; Cho YL; Tseng YZ
Br J Pharmacol; 2006 Apr; 147(8):944-50. PubMed ID: 16491102
[TBL] [Abstract][Full Text] [Related]
37. Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition.
Allen TJ; Hulthen UL; Rumble JR; Jasik M; Cooper ME
J Diabetes Complications; 1995; 9(4):318-22. PubMed ID: 8573756
[TBL] [Abstract][Full Text] [Related]
38. The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-beta expression.
Russo LM; Brammar GC; Jerums G; Comper WD; Osicka TM
J Hypertens; 2003 Feb; 21(2):419-28. PubMed ID: 12569274
[TBL] [Abstract][Full Text] [Related]
39. Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy.
Karadeniz T; Cavusoğlu T; Turkmen E; Uyanıkgil Y; Karadeniz M; Akdemir O; Tuglu MI; Ates U; Erbas O
Ren Fail; 2014 Sep; 36(8):1283-90. PubMed ID: 25010195
[TBL] [Abstract][Full Text] [Related]
40. Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
Davis BJ; Forbes JM; Thomas MC; Jerums G; Burns WC; Kawachi H; Allen TJ; Cooper ME
Diabetologia; 2004 Jan; 47(1):89-97. PubMed ID: 14647892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
